24front
deCODE genetics, an Amgen subsidiary headquartered in Reykjavik, Iceland, is a global leader in analyzing the human genome to identify genetic risk factors for common diseases. Using Iceland's unique population genetics resources, deCODE has discovered risk factors for dozens of conditions including cardiovascular disease, cancer, and neurological disorders, advancing drug discovery and development.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2012
Jul 2000
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
